HBS1L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.116000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.774800E-01
Normal-vs-Stage2
3.317400E-01
Normal-vs-Stage3
1.046460E-02
Normal-vs-Stage4
6.324600E-01
Stage1-vs-Stage2
9.171800E-01
Stage1-vs-Stage3
3.623800E-01
Stage1-vs-Stage4
4.262400E-01
Stage2-vs-Stage3
3.391800E-01
Stage2-vs-Stage4
4.652000E-01
Stage3-vs-Stage4
5.276200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.187600E-01
Normal-vs-AfricanAmerican
6.991400E-01
Normal-vs-Asian
6.920200E-02
Caucasian-vs-AfricanAmerican
3.629400E-01
Caucasian-vs-Asian
2.227800E-01
AfricanAmerican-vs-Asian
8.335800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.001000E-01
Normal-vs-Female
3.410600E-01
Male-vs-Female
2.946400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.818400E-02
Normal-vs-Age(41-60Yrs)
7.198600E-01
Normal-vs-Age(61-80Yrs)
1.408830E-01
Normal-vs-Age(81-100Yrs)
1.245420E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.594000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.751800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.287600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.412170E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.235640E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.098600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.055700E-02
Normal-vs-Daily Drinker
6.019300E-03
Normal-vs-Weekly Drinker
3.312000E-01
Normal-vs-Occasional Drinker
9.505800E-01
Normal-vs-Social Drinker
4.993800E-01
Non Drinker-vs-Daily Drinker
1.621170E-01
Non Drinker-vs-Weekly Drinker
3.107400E-01
Non Drinker-vs-Occasional Drinker
5.592500E-02
Non Drinker-vs-Social Drinker
1.892840E-01
Daily Drinker-vs-Weekly Drinker
3.508200E-02
Daily Drinker-vs-Occasional Drinker
1.390460E-02
Daily Drinker-vs-Social Drinker
4.483800E-02
Weekly Drinker-vs-Occasional Drinker
2.134600E-01
Weekly Drinker-vs-Social Drinker
7.849600E-01
Occasional Drinker-vs-Social Drinker
3.351200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.124800E-01
Normal-vs-Grade 2
8.850600E-01
Normal-vs-Grade 3
8.993800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.172600E-01
Grade 1-vs-Grade 3
8.524000E-01
Grade 1-vs-Grade 4
9.124800E-01
Grade 2-vs-Grade 3
7.962800E-01
Grade 2-vs-Grade 4
8.850600E-01
Grade 3-vs-Grade 4
8.993800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.421970E-01
Normal-vs-NonDiabetic
2.940200E-01
Diabetic-vs-NonDiabetic
5.683200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.182250E-02
Normal-vs-NoPancreatitis
3.103200E-01
Pancreatitis-vs-NoPancreatitis
1.082550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.156000E-01
Normal-vs-N1
3.304400E-01
N0-vs-N1
9.498400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.426600E-01
Normal-vs-TP53-NonMutant
7.047200E-01
TP53-Mutant-vs-TP53-NonMutant
1.196410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
